Anthropic's September 2026 threat report reveals Claude was used in five bioweapons-adjacent research attempts, including a chikungunya gain-of-function request. Here's why virologists and AI safety experts are both worried.
RAND says no single safeguard can stop AI-assisted bioweapons, and lays out nine layered defences. Here is what the report argues, why it lands now, and where it is still guesswork.
A new peer-reviewed study cut AI-redesigned toxin genes into fragments and fed them to four commercial DNA screening tools. Two caught fragments as short as 50 nucleotides. Here's what that means ten weeks before a US screening deadline — and why the authors are still worried.
OpenAI is giving 100,000 academic researchers free frontier model access with 75+ life science skills. Anthropic's newest flagship refuses to explain mitochondria. Both companies claim to be managing the same biosecurity risk — and the gap between their answers tells you how unsettled AI-for-biology governance really is.
